Disulfide based prodrugs for cancer therapy
Author:
Affiliation:
1. National Engineering Research Center for Nanomedicine
2. College of Life Science and Technology
3. Huazhong University of Science and Technology
4. Wuhan
5. China
Abstract
This review summarizes the progress in disulfide linker technology to balance extracellular stability and intracellular cleavage for optimized disulfide-containing prodrugs.
Funder
National Natural Science Foundation of China
Huazhong University of Science and Technology
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA04155F
Reference115 articles.
1. Prodrugs: design and clinical applications
2. Prodrug approach: An overview of recent cases
3. The expanding role of prodrugs in contemporary drug design and development
4. Mutual prodrug concept: Fundamentals and applications
5. Novel Mutual Prodrug of Retinoic and Butyric Acids with Enhanced Anticancer Activity
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interaction of disulfides with metal ions and spectroscopic identification of the products;Coordination Chemistry Reviews;2024-04
2. Oxime-Linked Peptide–Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview;International Journal of Molecular Sciences;2024-02-03
3. Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era;Biomedicines;2024-01-16
4. Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis;Chemical Science;2024
5. Glutathione‐triggered prodrugs: Design strategies, potential applications, and perspectives;Medicinal Research Reviews;2023-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3